nicotinamide n-oxide has been researched along with niacinamide in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (28.57) | 18.7374 |
1990's | 3 (14.29) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 5 (23.81) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kakehi, H; Matsuo, H; Shibata, K | 1 |
Dostert, P; Rovei, V; Smith, RL; Strolin Benedetti, M | 1 |
Kitamura, S; Mishima, H; Shimada, S; Tatsumi, K | 1 |
Nomura, K; Sano, K; Shimada, T; Shin, M; Umezawa, C | 1 |
Kitamura, S; Tatsumi, K | 1 |
Kitamura, S; Tatsumi, K; Wada, Y | 1 |
Dennis, MF; Stratford, MR | 1 |
Bernier, J; Bieri, S; Bolla, M; Denekamp, J; Dennis, MF; Hagen, F; Kocagöncü, O; Rojas, A; Stratford, MR | 1 |
Kitamura, S; Ohta, S; Sugihara, K; Takekawa, K | 1 |
Cutshall, NS; Ihle, NC; Kucera, KA; Latham, J; Ursino, R | 1 |
Iwata, K; Ogata, S; Okumura, K; Taguchi, H | 1 |
BLOCH, K; CHAYKIN, S | 1 |
Fukuwatari, T; Sasaki, R; Shibata, K; Wada, H | 1 |
Adams, MH; Cefali, EA; González, MA; Leu, JH; Menon, RM; Tolbert, DS | 2 |
Hirst, DG; Ruddock, MW | 1 |
Atac, A; Karabacak, M; Karaca, C; Kose, E | 1 |
Hong, S; Pissios, P; Real, AM | 1 |
Bercot, EA; Bio, MM; Huckins, JR; Hwang, TL; Thiel, OR | 1 |
Fukuwatari, T; Shibata, K; Suzuki, C | 1 |
Fukuwatari, T; Maeta, A; Sano, M; Shibata, K | 1 |
3 trial(s) available for nicotinamide n-oxide and niacinamide
Article | Year |
---|---|
Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
Topics: Administration, Oral; Area Under Curve; Carbon Dioxide; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Dose Fractionation, Radiation; Follow-Up Studies; Half-Life; Head and Neck Neoplasms; Humans; Lung Neoplasms; Nausea; Niacinamide; Oxygen; Pyridones; Radiation-Sensitizing Agents; Tablets; Time Factors; Treatment Outcome; Vomiting | 1998 |
Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites.
Topics: Adult; Area Under Curve; Drug Administration Schedule; Humans; Male; Middle Aged; Niacin; Niacinamide; Nicotinic Acids; Vitamin B Complex | 2007 |
Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation.
Topics: Adult; Cross-Over Studies; Delayed-Action Preparations; Humans; Male; Middle Aged; Niacin; Niacinamide; Nicotinic Acids; Vitamins | 2007 |
18 other study(ies) available for nicotinamide n-oxide and niacinamide
Article | Year |
---|---|
Niacin catabolism in rodents.
Topics: Animals; Cricetinae; Guinea Pigs; Kinetics; Male; Mice; Mice, Inbred ICR; Niacin; Niacinamide; Nicotinic Acids; Species Specificity | 1990 |
Can a 1,2-oxygen shift of a nicotinamide N-oxide derivative occur in vivo?
Topics: Animals; Carbon Radioisotopes; Niacinamide; Oxidation-Reduction; Rats | 1985 |
Nicotinamide N-oxide reductase activity in bovine and rabbit eyes.
Topics: Aldehyde Oxidase; Aldehyde Oxidoreductases; Animals; Cattle; Chemical Fractionation; Ciliary Body; Eye; Niacinamide; Oxidation-Reduction; Rabbits | 1987 |
Nicotinamide N-oxide formation by rat liver microsomes.
Topics: Animals; Chemical Phenomena; Chemistry; In Vitro Techniques; Male; Microsomes, Liver; Niacinamide; Rats; Rats, Inbred Strains | 1983 |
Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide.
Topics: Aldehyde Oxidase; Aldehyde Oxidoreductases; Anaerobiosis; Animals; Cricetinae; Cytosol; Guinea Pigs; Liver; Mice; Niacinamide; Oxidation-Reduction; Pyrimidines; Rabbits; Rats; Swine; Vitamin K | 1984 |
NAD (P) H-dependent reduction of nicotinamide N-oxide by an unique enzyme system consisting of liver microsomal NADPH-cytochrome C reductase and cytosolic aldehyde oxidase.
Topics: Aldehyde Oxidase; Aldehyde Oxidoreductases; Animals; Cytosol; Electron Transport; Male; Microsomes, Liver; NAD; NADP; NADPH-Ferrihemoprotein Reductase; Niacinamide; Rabbits | 1984 |
Pharmacokinetics and biochemistry studies on nicotinamide in the mouse.
Topics: Animals; Biological Availability; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Half-Life; Injections, Intraperitoneal; Male; Metabolic Clearance Rate; Mice; Neoplasms, Experimental; Niacinamide; Serotonin | 1994 |
Non-enzymatic reduction of aliphatic tertiary amine N-oxides mediated by the haem moiety of cytochrome P450.
Topics: Amines; Animals; Catalysis; Cyclic N-Oxides; Cytochrome P-450 Enzyme System; Flavins; Heme; Imipramine; In Vitro Techniques; Male; Microsomes, Liver; NADP; Niacinamide; Oxidation-Reduction; Oxidoreductases; Rats; Rats, Sprague-Dawley; Strychnine | 2001 |
Nicotinamide N-oxides as CXCR2 antagonists.
Topics: Autoimmune Diseases; Binding Sites; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Chemotaxis; Growth Substances; Humans; Hypersensitivity; Inflammation; Inhibitory Concentration 50; Intercellular Signaling Peptides and Proteins; Interleukin-8; Neutrophils; Niacinamide; Protein Binding; Receptors, Interleukin-8B; Structure-Activity Relationship | 2001 |
Expression of CD38 in human promyelocytic leukemia HL-60 cell line during differentiation by niacin-related compounds.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Cell Differentiation; Cell Membrane; Flow Cytometry; Gene Expression; HL-60 Cells; Humans; Isonicotinic Acids; Membrane Glycoproteins; Niacinamide; Tretinoin | 2003 |
The metabolism of nicotinamide-N-oxide.
Topics: Niacin; Niacinamide; Nicotinic Acids; Oxides | 1959 |
Effects of excess nicotinamide administration on the urinary excretion of nicotinamide N-oxide and nicotinuric acid by rats.
Topics: Animals; Dose-Response Relationship, Drug; Eating; Liver; Male; NAD; NADP; Niacinamide; Nicotinic Acids; Predictive Value of Tests; Quinolinic Acid; Rats; Rats, Wistar; Tryptophan; Weaning; Weight Gain | 2004 |
Metabolites of the radiosensitizer nicotinamide are unlikely to contribute to the degree of emesis observed with the parent drug.
Topics: Animals; Arteries; Ileum; Isotonic Solutions; Male; Niacinamide; Peristalsis; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Tail; Vasoconstriction; Vomiting | 2007 |
Spectroscopic (NMR, UV, FT-IR and FT-Raman) analysis and theoretical investigation of nicotinamide N-oxide with density functional theory.
Topics: Magnetic Resonance Spectroscopy; Models, Molecular; Niacinamide; Quantum Theory; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman | 2011 |
Nicotinamide N-oxidation by CYP2E1 in human liver microsomes.
Topics: Biotransformation; Catalysis; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Enzyme Inhibitors; Humans; Kinetics; Liver; Microsomes, Liver; Niacinamide; Oxidation-Reduction; Substrate Specificity; Vitamin B Complex | 2013 |
Rh(III)-catalyzed C-H activation and double directing group strategy for the regioselective synthesis of naphthyridinones.
Topics: Catalysis; Naphthyridines; Niacinamide; Rhodium; Stereoisomerism | 2013 |
Pharmacological doses of nicotinic acid and nicotinamide are independently metabolized in rats.
Topics: Animals; Diet; Drug Interactions; Male; Niacin; Niacinamide; Nicotinic Acids; Pyridones; Rats, Wistar | 2014 |
Simultaneous measurement of nicotinamide and its catabolites, nicotinamide N-oxide, N(1)-methyl-2-pyridone-5-carboxamide, and N(1)-methyl-4-pyridone-3-carboxamide, in mice urine.
Topics: Animals; Mice; Niacinamide; Pyridones; Time Factors; Urinalysis | 2014 |